Inhibition of the intestinal digoxin absorption and exsorption by quinidine

Drug Metabolism and Disposition

Volumn 24, Issue 2, 1996, Pages 142-147

  Sheng Fang, S U ^a   Huang, Jim Ding ^a  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLYLIMIDODIPHOSPHATE; DIGOXIN; GLYCOPROTEIN P; PROTEIN INHIBITOR; QUINIDINE SULFATE;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG INHIBITION; INTESTINE ABSORPTION; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; DIGOXIN; DRUG INTERACTIONS; EVALUATION STUDIES; INTESTINAL ABSORPTION; INTESTINE, SMALL; MALE; METABOLIC CLEARANCE RATE; P-GLYCOPROTEIN; QUINIDINE; RATS; RATS, SPRAGUE-DAWLEY;

EID: 9044245300     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. H. I. Bussey: The influence of quinidine and other agents on digitalis glycosides. Am. Heart J. 104, 289-302 (1982).
2. A. Mordel, H. Halkin, L. Zulty, S Almog, and D. Ezra: Quinidine enhances digitalis toxicity at therapeutic serum digoxin levels. Clin. Pharmacol Ther. 53, 457-462 (1993).
3. S. G. Schafer, G. Sehuhmann, W. Doering, and B. Fichtl: Influence of quinidine on the intestinal secretion of digoxin and digitoxin in guinea pigs. Chem.-Biol. Interact 55, 203-213 (1985).
4. K. Okudaira, Y. Sawada, Y. Sugiyama, T. Iga, and M. Hanano: Effect of quinidine on the hepatic uptake of digoxin in guinea pigs. J. Pharmacobiodyn. 12, 24-30 (1989).
5. 1). J. Pharmacol. Exp. Ther. 263, 840-845 (1992).
6. I. A. M. de Lannoy and M. Silverman: The MDRI gene product, P-glycoprotein, mediates the transport of the cardiac glycoside, digoxin. Biochem. Biophys. Res. Commun. 189, 551-557 (1992).
7. S. Ito, C. Woodland, P. A. Harper, and G. Koren: P-glycoprotein-mediated renal tubular secretion of digoxin-the lexicological significance of the urine-blood barrier model. Life Sci. 53, PL25-PL31 (1993).
8. R. Hori, N. Okamura, T. Aiba, and Y. Tanigawara: Role of P-glycoprotein in renal tubular secretion of digoxin in the isolated perfused rat kidney. J. Pharmacol. Exp. Ther. 266, 1620-1625 (1993).
9. N. Okamura, M. Hirai, Y. Tanigawara, K. Tanaka, M. Yasuhara, K. Ueda, T. Komano, and R. Hori: Digoxin-cyclosporin A-interacrion - modulation of the multidrug transporter P-glycoprotein in the kidney. J. Pharmacol. Exp. Ther. 266, 1614-1619 (1993).
10. I. A. M. de Lannoy, G. Koren, J. Klein, J. Charuk, and M. Silverman: Cyclosporin and quinidine inhibition of renal digoxin excretion: evidence for luminal secretion of digoxin. Am. J. Physiol. 263, F613-F622 (1992).
11. C.-J. Chen, J. E. Chin, K. Ueda, D. P. Clark, and I. Pastan: Internal duplication and homology with bacterial transport proteins in the marI (P-glycoprotein) gene from multidrug-resistant cells. Cell 47, 381-389 (1986).
12. P. Gros, J. Croop, and D. Housman: Mammalian multidrug resistance gene: complete cDNA sequence indicates strong homology to bacterial transport proteins. Cell 47, 371-380 (1986).
13. J. A. Endicott and V. Ling: The biochemistry of P-glycoprotein-mediated multidrug resistance. Annu. Rev. Biochem. 58, 137-171 (1989).
14. L. J. Goldstein, H. Galski, A. Fojo, M. Willingham, S. Lai, A. Gazdar, R. Pirker, A. Green, W. Crist, G. Brodeur, C. Grant, M. Leiber, J. Cossmann, M. M. Gottesman, and I. Pastan: Expression of a multidrug resistance gene in human cancers. J. Natl. Cancer Inst. 81, 116-124 (1989).
15. A. T. Fojo, K. Ueda, D. J. Slamon, D. G. Poplack, M. M. Gottesman, and I. Pastan: Expression of a multidrug-resistance gene in human tumors and tissues. Proc. Natl. Acad. Sci. U.S.A. 84, 265-269 (1987).
16. F. Thiebaut, T. Tsuruo, H. Hamada, M. M. Gottesman, I. Pastan, and M. C. Willingham: Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues. Proc. Natl. Acad. Sci. U.S.A. 84, 7735-7738 (1987).
17. J. M. Croop, M. Raymond, D. Haber, A. Devault, R. J. Arceci, P. Gros, and D. Horsman: The three multidrug resistance (mdr) genes are expressed in a tissue-specific manner in normal mouse tissue. Mol. Cell. Biol. 9, 1346-1350 (1989).
18. S. Hsing, Z. Gatmaitan, and I. M. Arias: The function of Gp170, the multidrug-resistance gene product, in the brush border of rat intestinal mucosa. Gastroenterology 102, 879-885 (1992).
19. B. L. Leu and J. D. Huang: Inhibition of intestinal P-glycoprotein and effects on etoposide absorption. Cancer Chemother. Pharmacol. 35, 432-436 (1995).
20. I. Pastan and M. M. Gottesman: Multiple-drug resistance in human cancer. N. Engl. J. Med. 316, 1388-1393 (1987).
21. J. M. Ford and W. N. Hait: Pharmacology of drugs that alter multidrug resistance in cancer Pharmacol. Rev. 42, 155-199 (1990).
22. T. Tsuruo, H Iida, Y. Kitatani, K. Yokota, S. Tsukagoshi, and Y. Sakurai: Effects of quinidine and related compounds on cytotoxicity and cellular accumulation of vincristine 'and adriamycin in drug-resistance tumor cells. Cancer Res. 44, 4303-4307 (1984).
23. M. M. Cornwell, I. Pastan, and M. M. Gottesman: Certain calcium channel blockers bind specifically to multidrug-resistance human KB carcinoma membrane vesicles and inhibit drug binding to P-glycoprotein. J. Biol. Chem. 262, 2166-2170 (1987).
24. J. D. Huang: Comparative drag exsorption in the perfused rat intestine. J Pharm. Pharmacol. 42, 167-170 (1990).
25. J. D. Huang: Effect of altered serum protein binding on intestinal clearance of S-disopyramide in rats. Asia Pacific J. Pharmacol. 4, 257-263 (1989).
26. B. Desta and K. M. McErlane: High-performance liquid chromatographic analysis of digoxin formulations. J. Pharm. Sci. 71, 777-780 (1982).
27. R. S. Weinstein, J. R. Kuszak, L. F. Kluskens, and J. S. Coon: P-glycoprotein in pathology: the multidrug resistance gene family in humans. Human Pathol. 21, 43-48 (1990).
28. L. A. Mickley, S. E. Bates, N. D. Richer, S. Currier, S. Tanaka, F. Foss, N. Rosen, and A. T. Fojo: Modulation of the expression of a multidrug resistance gene (mdrl/P-glycoprotein) by differentiating agents. J. Biol. Chem. 264, 18031-18040 (1989).
29. K.-V. Chin, S. Tanaka, G. Darlington, I. Pastan, and M. M. Gottesman: Heat shock and arsenite increase expression of the multidrug resistance (MDR1) gene in human renal carcinoma cells. J. Biol. Chem. 265, 221-226 (1990).
30. N. Kioka, N. Hosokawa, T. Komano, K. Hirayoshi, K. Nagata, and K. Ueda: Quercetin, a bioflavonoid, inhibits the increase of human multidrug resistance gene (mdr1) expression caused by arsenite. FEBS J. 301, 307-309 (1992).
31. B. Angelin, A. Arvidsson, R. Dahlqvist, A. Hedman, and K. Schenck-Gustafsson: Quinidine reduces biliary clearance of digoxin in man. Eur. J. Clin. Invest. 17, 262-265 (1987).